4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-018780
Chief Accounting Officer sold 494 shares at $0.70 ($343)
From the SEC's structured data for this filing
Trades in this filing
Hagen Brett R · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-20 | Sale : show line 1 in the form | −494 | $0.70 | $343 | 78,853 | D |
| Open-market sales · 494 sh · avg $0.70 · $343 | ||||||
Loading xslF345X05/ownership.xml…